EVOKE PHARMA, INC. Operating Lease, Payments
EVOKE PHARMA, INC. reported Operating Lease, Payments of $19.37 thousand for the 3-month period ending 2025-09-30, per its 10-Q filed 2025-11-13.
Financial Statements › Cash Flow
us-gaap:OperatingLeasePayments · last filed 2025-11-13
- EVOKE PHARMA, INC. operating lease, payments for the quarter ending 2025-09-30 was $19.37K, a 2.05% increase year-over-year.
- EVOKE PHARMA, INC. operating lease, payments for the quarter ending 2025-06-30 was $19.37K, a 2.14% increase year-over-year.
- EVOKE PHARMA, INC. operating lease, payments for the quarter ending 2025-03-31 was $19.37K, a 2.29% increase year-over-year.
- EVOKE PHARMA, INC. operating lease, payments for the quarter ending 2024-12-31 was $12.69K, a 51.18% decline year-over-year.
- EVOKE PHARMA, INC. operating lease, payments for fiscal 2024 was $69.58K, a 52.45% decline from fiscal 2023.
- EVOKE PHARMA, INC. operating lease, payments for fiscal 2023 was $146.33K, a 275.20% increase from fiscal 2022.
- EVOKE PHARMA, INC. operating lease, payments for fiscal 2022 was $39.00K, a 71.53% decline from fiscal 2021.
- EVOKE PHARMA, INC. operating lease, payments for fiscal 2021 was $137.00K.
| Period end | Operating Lease, Payments 3 month | Operating Lease, Payments 3 month as first filed | Operating Lease, Payments 6 month | Operating Lease, Payments 9 month | Operating Lease, Payments 9 month as first filed | Operating Lease, Payments 12 month | Operating Lease, Payments 12 month as first filed |
|---|---|---|---|---|---|---|---|
| 2025-09-30 | $19.37K 10-Q · filed 2025-11-13 | $38.74K derived: sum of 2 quarters · filed 2025-11-13 | $58.11K 10-Q · filed 2025-11-13 | $70.80K derived: sum of 4 quarters · filed 2025-11-13 | |||
| 2025-06-30 | $19.37K 10-Q · filed 2025-08-14 | $38.74K 10-Q · filed 2025-08-14 | $51.43K derived: sum of 3 quarters · filed 2025-08-14 | $70.41K derived: sum of 4 quarters · filed 2025-11-13 | |||
| 2025-03-31 | $19.37K 10-Q · filed 2025-05-13 | $32.06K derived: sum of 2 quarters · filed 2025-05-13 | $51.04K derived: sum of 3 quarters · filed 2025-11-13 | $70.01K derived: sum of 4 quarters · filed 2025-11-13 | |||
| 2024-12-31 | $12.69K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-13 | $31.67K derived: sum of 2 quarters · filed 2025-11-13 | $50.64K derived: sum of 3 quarters · filed 2025-11-13 | $69.58K 10-K · filed 2025-03-13 | |||
| 2024-09-30 | $18.98K 10-Q · filed 2025-11-13 | $37.95K derived: sum of 2 quarters · filed 2025-11-13 | $56.88K 10-Q · filed 2025-11-13 | $82.88K derived: sum of 4 quarters · filed 2025-11-13 | |||
| 2024-06-30 | $18.97K 10-Q · filed 2025-08-14 | $37.90K 10-Q · filed 2025-08-14 | $63.90K derived: sum of 3 quarters · filed 2025-08-14 | $104.01K derived: sum of 4 quarters · filed 2025-08-14 | |||
| 2024-03-31 | $18.94K 10-Q · filed 2025-05-13 | $44.93K derived: sum of 2 quarters · filed 2025-05-13 | $85.04K derived: sum of 3 quarters · filed 2025-05-13 | $125.15K derived: sum of 4 quarters · filed 2025-05-13 | |||
| 2023-12-31 | $25.99K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-13 | $66.11K derived: sum of 2 quarters · filed 2025-03-13 | $106.22K derived: sum of 3 quarters · filed 2025-03-13 | $146.33K 10-K · filed 2025-03-13 | $146.00K 10-K · filed 2024-03-14 | ||
| 2023-09-30 | $40.11K 10-Q · filed 2023-11-09 | $80.22K derived: sum of 2 quarters · filed 2023-11-09 | $120.33K 10-Q · filed 2023-11-09 | $47.49K derived: sum of 4 quarters · filed 2024-05-14 | |||
| 2023-06-30 | $40.11K 10-Q · filed 2023-08-10 | $80.22K 10-Q · filed 2023-08-10 | $7.38K derived: sum of 3 quarters · filed 2024-05-14 | $44.66K derived: sum of 4 quarters · filed 2024-05-14 | |||
| 2023-03-31 | $40.11K 10-Q · filed 2023-05-15 | -$32.73K derived: sum of 2 quarters · filed 2024-05-14 | $4.55K derived: sum of 3 quarters · filed 2024-05-14 | $41.83K derived: sum of 4 quarters · filed 2024-05-14 | |||
| 2022-12-31 | -$72.84K derived: 10-K/A 12 month − 10-Q 9 month · filed 2024-05-14 | -$35.56K derived: sum of 2 quarters · filed 2024-05-14 | $1.72K derived: sum of 3 quarters · filed 2024-05-14 | $39.00K 10-K/A · filed 2024-05-14 | |||
| 2022-09-30 | $37.28K 10-Q · filed 2023-11-09 | $12.43K 10-Q · filed 2022-11-09 | $74.56K derived: sum of 2 quarters · filed 2023-11-09 | $111.84K 10-Q · filed 2023-11-09 | $12.43K 10-Q · filed 2022-11-09 | $149.43K derived: sum of 4 quarters · filed 2023-11-09 | |
| 2022-06-30 | $37.28K 10-Q · filed 2023-08-10 | $74.56K 10-Q · filed 2023-08-10 | $112.14K derived: sum of 3 quarters · filed 2023-08-10 | $149.43K derived: sum of 4 quarters · filed 2023-08-10 | |||
| 2022-03-31 | $37.28K 10-Q · filed 2023-05-15 | $74.86K derived: sum of 2 quarters · filed 2023-05-15 | $112.14K derived: sum of 3 quarters · filed 2023-05-15 | ||||
| 2021-12-31 | $37.58K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-21 | $74.86K derived: sum of 2 quarters · filed 2023-03-21 | $137.00K 10-K · filed 2023-03-21 | ||||
| 2021-09-30 | $37.28K 10-Q · filed 2022-11-09 | $99.42K 10-Q · filed 2022-11-09 |